Addressing Hospital-Acquired Conditions (HACs) after COVID-19 – Part 5

In this final episode of our series on HACs, we examine the challenge of Clostridium difficile infection (C. diff, or CDI) for clinicians and patients. Highly infectious and unsusceptible to alcohol, CDI is cause for concern, with infection rates rising after COVID-19, as they are for all HACs. Yet, a systematic approach according to new guidelines can curb and eliminate this condition.

 

Guest speaker:

Richard Beaver, B.S. Chem, MBB, CPHQ

Senior Consulting Director

Vizient

 

Moderator:

Tomas Villanueva, DO, MBA, FACPE, SFHM

Principal

Clinical Operations and Quality

Vizient

 

Show Notes:

[00:31] New CDI guidelines

[01:21] Insight on major causes – and an example

[03:31] Benefit of early detection at hospital

[05:57] Issues with testing protocols, isolation practices and use of antibiotics

[09:21] A multi-faceted approach

 

Links | Resources:

Rick Beaver’s contact email: richard.beaver@vizientinc.com

New CDI guidelines (IDSA and SHEA) Click here

CMS Hospital-Acquired Condition (HAC) fact sheet Click here

CMS Hospital-Acquired Condition (HAC) reduction program Click here

Information on Vizient’s Clinical Data Base (CDB) Click here

AHRQ tools to reduce HACs Click here

 

Subscribe Today!

Apple Podcasts

Spotify

Android

Google Podcasts

Stitcher

RSS Feed